affiliate disclosure · We earn affiliate commission on some vendor links. Audits, scores, and rankings are independent — vendors do not pay for placement and do not see drafts. read more →
AOD-9604 vs Tesamorelin
Two compounds, mechanism by mechanism. Where they overlap, where they don't, and which vendors stock each.
Mechanism
AOD-9604
Synthetic 16-amino-acid fragment of human growth hormone (residues 176–191). Selectively retains the lipolytic effect of HGH while reducing growth-related effects.
Full guide →Tesamorelin
Synthetic 44-amino-acid analog of growth hormone-releasing hormone (GHRH). Stimulates pituitary release of endogenous growth hormone in a pulsatile manner.
Full guide →Key facts
Use-case overlap
- fat metabolism research
- lipolysis studies
- HGH fragment research
none
- visceral fat reduction
- GHRH analog research
- HIV-associated lipodystrophy (FDA-approved indication)
Where to buy
Sources
- [01]AOD-9604 and obesity research — Obesity Reviews· AOD-9604
- [02]AOD-9604 Phase 2 trial results· AOD-9604
- [03]Effects of tesamorelin on visceral adipose tissue — JAMA· Tesamorelin
- [04]FDA approval label — Egrifta· Tesamorelin
Other peptide matchups
Receipts in your inbox. Once a month.
New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.